(Q38054513)

27 August 2017

title

Acute and acute severe (fulminant) autoimmune hepatitis (English)

1 reference

27 August 2017

Albert J Czaja

1

1 reference

27 August 2017

publication date

23 October 2012

1 reference

Digestive Diseases and Sciences

27 August 2017

published in

1 reference

27 August 2017

volume

58

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

897-914

1 reference

'Acute' autoimmune hepatitis

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Our experience with fulminant hepatic failure in Turkish children: etiology and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Fulminant hepatic failure in an African setting: etiology, clinical course, and predictors of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune fulminant liver failure in adults: Experience in a Japanese center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Changing etiologies and outcomes of acute liver failure: A perspective from Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Acute presentation of autoimmune hepatitis: Does it exist? A published work review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Acute liver failure in Japan: definition, classification, and prediction of the outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Drug-induced active chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Clinical epidemiology of fulminant hepatitis in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Fulminant hepatitis and late onset hepatic failure in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune acute liver failure: proposed clinical and histological criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Drug-induced chronic liver disease, with emphasis on chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Drug-induced autoimmune-like hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Treatment challenges and investigational opportunities in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Type I autoimmune hepatitis is primarily a disease of later life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Simplified criteria for the diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune hepatitis with centrilobular necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune hepatitis in children: an overview of the disease focusing on current therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Steroid treatment for severe acute cryptogenic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Liver transplantation for autoimmune hepatitis: fulminant versus chronic hepatitis presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

The clinical challenges of acute on chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune hepatitis triggered by acute hepatitis A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune hepatitis following hepatitis A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune hepatitis with acute presentation in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoantibody-negative autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune hepatitis. Part A: pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Altered major histocompatibility complex-restricted antigen recognition by T cells from elderly humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Immune senescence: mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Reciprocal change with age in antibody to extrinsic and intrinsic antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Hypothesis: The Aging Paradox and Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune hepatitis. Part B: diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Optimizing diagnosis from the medical liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Histological findings in chronic hepatitis C with autoimmune features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Diagnosis and management of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Predictors of outcome in acute-on-chronic liver failure in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune hepatitis--sequel of a relapsing hepatitis A in a 75-year-old woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Persistent measles virus genome in autoimmune chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferon-alpha 2b plus ribavirin treatment showing histological heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Development of autoimmune hepatitis in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Risk factors for recurrence of autoimmune hepatitis after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

AASLD position paper: the management of acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Acute liver failure: redefining the syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Late onset hepatic failure: clinical, serological and histological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Fulminant and subfulminant liver failure: definitions and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Systematic review: acute liver failure - one disease, more than 40 definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Living donor liver transplantation for acute liver failure: a 10-year experience in a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Cryptogenic chronic hepatitis and its changing guise in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Performance parameters of the diagnostic scoring systems for autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Early indicators of prognosis in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Fulminant hepatic failure in children: etiology, histopathology and MDCT findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Severe autoimmune neutropenia associated with acute autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

CT of benign hypervascular liver nodules in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Fas polymorphisms influence susceptibility to autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Selection of patients for liver transplantation and allocation of donated livers in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Long-term prognosis in patients with severe late radiation enteropathy: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Advances in the current treatment of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Long-term outcome of liver transplantation for autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Drug choices in autoimmune hepatitis: part B--Nonsteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune hepatitis: focusing on treatments other than steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Drug choices in autoimmune hepatitis: part A--Steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Immunosuppressive drugs: the first 50 years and a glance forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Oral prednisone for chronic active liver disease: dose responses and bioavailability studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Corticosteroid Pharmacokinetics in Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Liver transplantation for autoimmune hepatitis: a single-center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Autoimmune hepatitis in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Is autoimmune chronic active hepatitis a HCV-related disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2445-4

Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part II.

21 January 2018

1 reference

12 December 2020

Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C

1 reference

12 December 2020

1 reference

12 December 2020

Steroid therapy in fulminant hepatic failure secondary to autoimmune hepatitis

1 reference

12 December 2020

Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease

1 reference

12 December 2020

Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis

1 reference

12 December 2020

Performance parameters of the conventional serological markers for autoimmune hepatitis

1 reference

12 December 2020

1 reference

12 December 2020

Risk factors for fulminant hepatic failure and their relation with outcome in children.

1 reference

12 December 2020

Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation

1 reference

12 December 2020

Behavior and significance of autoantibodies in type 1 autoimmune hepatitis

1 reference

12 December 2020

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

1 reference

12 December 2020

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

12 December 2020

Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR findings

1 reference

12 December 2020

Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience

1 reference

12 December 2020

A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis

1 reference

12 December 2020

Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitis

1 reference

12 December 2020

Subfulminant hepatic failure in autoimmune hepatitis type 1: an unusual form of presentation

1 reference

12 December 2020

Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I.

1 reference

12 December 2020

Autoimmune hepatitis in the material of Department and Regional Hospital of Infectious Diseases in Gdańsk

1 reference

12 December 2020

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

12 December 2020

Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.

1 reference

12 December 2020

Current problems in the diagnosis and management of chronic active hepatitis

1 reference

12 December 2020

Advanced histology and impaired liver regeneration are associated with disease severity in acute-onset autoimmune hepatitis

1 reference

12 December 2020

Failure of customary treatment in chronic active liver disease: causes and management

1 reference

12 December 2020

Bioavailability and reversible metabolism of prednisone and prednisolone in man

1 reference

12 December 2020

Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis

1 reference

12 December 2020

Reevaluation of the nomenclature and diagnostic criteria in 477 patients with severe hepatitis

1 reference

12 December 2020

Prevalence of autoimmune liver disease in Alaska Natives

1 reference

12 December 2020

Autoantibodies in autoimmune liver disease

1 reference

12 December 2020

Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis

1 reference

12 December 2020

Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure

1 reference

12 December 2020

Cyclosporine treatment of autoimmune chronic active hepatitis

1 reference

12 December 2020

Drug-induced chronic liver disease

1 reference

12 December 2020

Autoimmune hepatitis: CT and MR imaging features with histopathological correlation

1 reference

12 December 2020

Meeting report: International Autoimmune Hepatitis Group

1 reference

12 December 2020

Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival

1 reference

12 December 2020

Diagnostic criteria of acute liver failure: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan

1 reference

12 December 2020

Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis

1 reference

12 December 2020

A case of cyclosporine-sensitive, steroid-resistant, autoimmune chronic active hepatitis

1 reference

12 December 2020

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

1 reference

12 December 2020

Severe chronic active liver disease. Prognostic significance of initial morphologic patterns

1 reference

12 December 2020

Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.

1 reference

12 December 2020

Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly

1 reference

12 December 2020

Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C

1 reference

12 December 2020

Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone

1 reference

12 December 2020

Clinicopathological features of acute-onset autoimmune hepatitis

1 reference

12 December 2020

Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial

1 reference

12 December 2020

Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver disease

1 reference

12 December 2020

A novel histological lesion in glucocorticoid-responsive chronic hepatitis

1 reference

12 December 2020

Importance of computed tomography imaging features for the diagnosis of autoimmune acute liver failure

1 reference

12 December 2020

Autoimmune hepatitis induced by the prolonged hepatitis A virus infection.

1 reference

12 December 2020

Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis

1 reference

12 December 2020

Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases

1 reference

12 December 2020

De-novo autoimmune hepatitis after liver transplantation

1 reference

12 December 2020

Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria

1 reference

12 December 2020

Acute-onset autoimmune hepatitis resembling acute hepatitis: a case report and review of reported cases.

1 reference

12 December 2020

Recent-onset autoimmune hepatitis. Biopsy findings and clinical correlations

1 reference

12 December 2020

Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentre study. The Study Group of Fulminant Hepatitis

1 reference

12 December 2020

Autoimmune hepatitis with initial presentation as acute hepatic failure in young children

1 reference

12 December 2020

Autoimmune chronic active hepatitis masquerading as acute hepatitis

1 reference

12 December 2020

Clinicopathological features of severe and fulminant forms of autoimmune hepatitis

1 reference

12 December 2020

Novel scoring system as a useful model to predict the outcome of patients with acute liver failure: Application to indication criteria for liver transplantation

1 reference

12 December 2020

Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype

1 reference

12 December 2020

A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality

1 reference

12 December 2020

A classification of chronic hepatitis

1 reference

12 December 2020

Clinical assessment of cirrhosis in severe chronic active liver disease: specificity and sensitivity of physical and laboratory findings.

1 reference

12 December 2020

Pathology of autoimmune liver diseases in children

1 reference

12 December 2020

Pathogenesis of autoimmune hepatitis

1 reference

12 December 2020

Measles-specific nucleotide sequences and autoimmune chronic active hepatitis

1 reference

12 December 2020

Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis

1 reference

12 December 2020

A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1

1 reference

12 December 2020

Autoimmune hepatitis: the investigational and clinical challenges

1 reference

12 December 2020

The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study

1 reference

12 December 2020

Safety issues in the management of autoimmune hepatitis

1 reference

12 December 2020

T-cell function in aging: mechanisms of decline

1 reference

12 December 2020

The role of autoantibodies as diagnostic markers of autoimmune hepatitis

1 reference

12 December 2020

The nature and prognostic implications of autoimmune hepatitis with an acute presentation

1 reference

12 December 2020

Autoimmune chronic active hepatitis developing after acute type B hepatitis

1 reference

12 December 2020

Autoimmune chronic hepatitis exacerbated by alpha-interferon

1 reference

12 December 2020

The management of fulminant hepatic failure.

1 reference

12 December 2020

HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients

1 reference

12 December 2020

1 reference

12 December 2020

Subacute hepatic failure; is it a distinct entity?

1 reference

12 December 2020

Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis

1 reference

12 December 2020

Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure.

1 reference

12 December 2020

10.1007/S10620-012-2445-4

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1021147835

0 references

1 reference